Positive news flow over the coming year should help close the gap between the share price of ChemGenex and ABN Amro Morgans’ calculated value, the broker believes.
An interest rate rise is on the cards, TD Securities says, but argues that a reactive move in August is the most likely outcome.
The shares are considered a long term buy as profits are expected to soar over the next years. FY09 net profit is estimated at $93.5m.
CommSec and JP Morgan join the growing list of brokers calling for a return to upside, albeit with a little less of the euphoria we’ve enjoyed in recent times.
Although the stock is hardly covered elsewhere, analysts at Austock feel Clive Peeters is worth a look, particularly in light of its recent store expansion plan.
Rumours are flying around regarding troubled packaging giant Amcor. Now a newspaper has mentioned interest from Graeme Hart.
Citigroup believes high-yielding REIT Macquarie DDR has been unfairly treated and now offers considerable value, even in the face of interest rate rises.
JP Morgan sees an opportunity in Candle Australia as increased IT spending and past acquisitions should guarantee strong profit growth.
By Chris Shaw The decision by CSL (CSL) management to bring forward a contingency payment of US$250m relating to the…
UBS is very excited about UK "last mile" utility Inexus, 80% owned by Challenger Infra, which it sees as offering 60% upside.